Cross-Site Scripting Vulnerability in Redaxo by Redaxo Team
CVE-2024-25300

4.8MEDIUM

Key Information:

Vendor

Redaxo

Status
Redaxo
Vendor
CVE Published:
14 February 2024

What is CVE-2024-25300?

The vulnerability in Redaxo v5.15.1 enables attackers to exploit a cross-site scripting (XSS) flaw through a crafted payload in the Name parameter within the Template section. This allows for the execution of arbitrary scripts or HTML, potentially leading to unauthorized actions or data theft. It is essential for users to understand the implications of this vulnerability and take necessary precautions to safeguard their applications. Mitigation may involve input validation and sanitization to prevent malicious scripts from being executed.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

References

https://github.com/WoodManGitHub/MyCVEs/blob/main/2024-RE...

CVSS V3.1

Score:
4.8
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.